Search

everythinglearnresearchcommunity

for

Search:↓

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Removing the liver tumor improved the patient's skin condition and hair growth.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Secukinumab can cause hair loss, which may improve after stopping the medication.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Mogamulizumab can cause hair loss and skin rashes.

Using a patient's own fat tissue helped treat hair loss caused by an injury.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Psoriasis can cause temporary or permanent hair loss.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Targeting specific cell interactions may help treat skin fibrosis.

A young man was diagnosed with trichoepitheliomas, causing thick skin and hair loss.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

A 2-year-old boy with a rare type of lupus causing hair loss improved with oral steroids.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Squaric acid dibutylester effectively treats alopecia areata.

Managing multiple autoimmune diseases in one patient is very challenging.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.